Trial news: We currently have 4 studies open to recruitment and 19 studies in follow up.
The table below details the trials that are currently accruing patients.
| Recruited | Target | Date of First Site Open (ANZ) | Number of Sites Open | End of Recruitment | |
| BIL-PPP (Cholangiocarcinoma) | 24 | 40 | 18 October 2024 | 8 | April 2029 |
| BIOMARCER-2 (Colorectal Cancer) | 2 | 11 | 6 August 2024 | 11 | August 2027 |
| MR-STAR (Abdominal Cancer) | 0 | 30 | 07 July 2025 | 2 | January 2027 |
| STOPNET (NeuroEndocrine Tumours (NETs)) | 40 | 78 | 9 September 2024 | 18 | September 2026 |